MERIDIAN BIOSCIENCE
VIVO Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2023-01-31
2023-01-31
ELLINGWOOD DWIGHT
D - Sale to Issuer
Stock Option (Right to Buy)
-82,897
$18.00
-1.49M
9
$0
2023-01-31
2023-01-31
MCILWRAITH JOHN
D - Sale to Issuer
Stock Option (Right to Buy)
-76,397
$18.00
-1.38M
8
$0
2023-01-31
2023-01-31
RICE JOHN MCCUNE JR.
D - Sale to Issuer
Stock Option (Right to Buy)
-32,192
$16.00
-515K
4
$0
2023-01-31
2023-01-31
SAZDANOFF CATHERINE
D - Sale to Issuer
Stock Option (Right to Buy)
-78,397
$18.00
-1.41M
8
$0
2023-01-31
2023-01-31
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
D - Sale to Issuer
Stock Option (Right to Buy)
-37,776
$18.00
-680K
4
$0
2023-01-31
2023-01-31
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
D - Sale to Issuer
Common Stock
-43,338
1
$0
2023-01-31
2023-01-31
SMITH JULIE DIANA
Sr VP, Controller, PAO
D - Sale to Issuer
Stock Option (Right to Buy)
-2,000
$27.00
-54,000
1
$0
2023-01-31
2023-01-31
SMITH JULIE DIANA
Sr VP, Controller, PAO
D - Sale to Issuer
Common Stock
-58,308
2
$0
2023-01-31
2023-01-31
WELTZIEN LOURDES
Executive VP, Life Science
D - Sale to Issuer
Stock Option (Right to Buy)
-36,276
$15.00
-544K
4
$0
2023-01-31
2023-01-31
WELTZIEN LOURDES
Executive VP, Life Science
D - Sale to Issuer
Common Stock
-86,045
1
$0
2023-01-31
2023-01-31
WILLIAMS FELICIA
D - Sale to Issuer
Stock Option (Right to Buy)
-49,397
$19.00
-939K
5
$0
2023-01-31
2023-01-31
KITZMILLER ANDREW
Executive Vice President & CFO
A - Grant
Common Stock
7,945
1
$0
2023-01-31
2023-01-31
ANDERSON JAMES
D - Sale to Issuer
Stock Option (Right to Buy)
-86,897
$17.00
-1.48M
9
$0
2023-01-31
2023-01-31
BIHL ANTHONY III
D - Sale to Issuer
Stock Option (Right to Buy)
-16,047
$12.00
-193K
3
$0
2023-01-31
2023-01-31
KENNY JOHN
Chief Executive Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-233K
$18.00
-4.19M
3
$0
2023-01-31
2023-01-31
KITZMILLER ANDREW
Executive Vice President & CFO
D - Sale to Issuer
Stock Option (Right to Buy)
-5,000
$9.00
-45,000
1
$0
2023-01-31
2023-01-31
KITZMILLER ANDREW
Executive Vice President & CFO
D - Sale to Issuer
Common Stock
-19,473
1
$0
2022-12-06
2022-12-07
SMITH JULIE DIANA
Sr VP, Controller, PAO
F - Tax
Common Stock
-374
$32.00
-11,968
1
$0
2022-11-15
2022-11-17
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
F - Tax
Common Stock
-3,666
$32.00
-117K
1
$0
2022-11-15
2022-11-17
SMITH JULIE DIANA
Sr VP, Controller, PAO
F - Tax
Common Stock
-1,845
$32.00
-59,040
1
$0
2022-11-04
2022-11-08
SMITH JULIE DIANA
Sr VP, Controller, PAO
F - Tax
Common Stock
-397
$32.00
-12,704
1
$0
2022-11-04
2022-11-08
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
F - Tax
Common Stock
-788
$32.00
-25,216
1
$0
2022-09-16
2022-10-05
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
F - Tax
Common Stock
-357
$32.00
-11,424
1
$0
2022-09-16
2022-10-05
SMITH JULIE DIANA
Sr VP, Controller, PAO
F - Tax
Common Stock
-360
$32.00
-11,520
1
$0
2022-06-27
2022-06-28
KENNY JOHN
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-61,437
$0.00
1
$0
2022-06-27
2022-06-28
KENNY JOHN
Chief Executive Officer
M - Exercise
Common Stock
61,437
$10.00
614K
1
$0
2022-06-24
2022-06-28
KENNY JOHN
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-13,559
$0.00
1
$0
2022-06-24
2022-06-28
KENNY JOHN
Chief Executive Officer
M - Exercise
Common Stock
13,559
$10.00
136K
1
$0
2022-06-23
2022-06-24
KENNY JOHN
Chief Executive Officer
M - Exercise
Common Stock
19,956
$11.00
220K
2
$0
2022-06-23
2022-06-24
KENNY JOHN
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-19,956
$0.00
2
$0
2022-06-22
2022-06-24
KENNY JOHN
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-44,651
$0.00
1
$0
2022-06-22
2022-06-24
KENNY JOHN
Chief Executive Officer
M - Exercise
Common Stock
44,651
$15.00
670K
1
$0
2022-02-21
2022-02-22
KITZMILLER ANDREW
EVP & CFO
A - Grant
Stock Options (Right to Buy)
5,000
$0.00
1
$0
2022-02-15
2022-02-17
WELTZIEN LOURDES
EVP, Life Science
M - Exercise
Stock Options (Right to Buy)
-20,000
$0.00
2
$0
2022-02-15
2022-02-17
WELTZIEN LOURDES
EVP, Life Science
M - Exercise
Common Stock
20,000
$15.00
300K
2
$0
2021-11-15
2021-12-16
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
F - Tax
Common Stock
-2,232
$20.00
-44,640
1
$0
2021-11-15
2021-11-16
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
J - Other
Common Stock
-24,343
1
$0
2021-11-04
2021-11-08
KENNY JOHN
Chief Executive Officer
A - Grant
Stock Options (Right to Buy)
82,940
$0.00
1
$0
2021-11-04
2021-11-08
BALDASARE BRYAN
Exec VP & CFO
A - Grant
Stock Options (Right to Buy)
11,669
$0.00
1
$0
2021-11-04
2021-11-08
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
A - Grant
Stock Options (Right to Buy)
11,669
$0.00
1
$0
2021-11-04
2021-11-08
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
A - Grant
Common Stock
10,593
$0.00
1
$0
2021-11-04
2021-11-08
WELTZIEN LOURDES
EVP, Life Science
A - Grant
Stock Options (Right to Buy)
11,669
$0.00
1
$0
2021-02-16
2021-02-17
KENNY JOHN
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-2,082
$0.00
1
$0
2021-02-16
2021-02-17
KENNY JOHN
Chief Executive Officer
M - Exercise
Common Stock
2,082
$10.00
20,820
1
$0
2021-02-12
2021-02-16
KENNY JOHN
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-23,097
$0.00
1
$0
2021-02-12
2021-02-16
KENNY JOHN
Chief Executive Officer
M - Exercise
Common Stock
23,097
$10.00
231K
1
$0
2021-02-11
2021-02-16
KENNY JOHN
Chief Executive Officer
M - Exercise
Common Stock
1,164
$10.00
11,640
1
$0
2021-02-11
2021-02-16
KENNY JOHN
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-1,164
$0.00
1
$0
2021-02-08
2021-02-10
KENNY JOHN
Chief Executive Officer
M - Exercise
Common Stock
66,134
$13.00
860K
2
$0
2021-02-08
2021-02-10
KENNY JOHN
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-66,134
$0.00
2
$0
2021-02-08
2021-02-09
BALDASARE BRYAN
Exec VP & CFO
M - Exercise
Stock Options (Right to Buy)
-3,750
$0.00
1
$0
2021-02-05
2021-02-08
BALDASARE BRYAN
Exec VP & CFO
M - Exercise
Stock Options (Right to Buy)
-11,250
$0.00
1
$0
2020-11-05
2020-11-09
KENNY JOHN
Chief Executive Officer
A - Grant
Stock Options (Right to Buy)
83,535
$0.00
1
$0
2020-11-05
2020-11-09
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
A - Grant
Stock Options (Right to Buy)
12,107
$0.00
1
$0
2020-11-05
2020-11-09
SERAFINI-LAMANNA TONY
Executive VP-Diagnostics
A - Grant
Common Stock
10,823
$0.00
1
$0
2020-11-05
2020-11-09
WELTZIEN LOURDES
EVP, Life Science
A - Grant
Stock Options (Right to Buy)
12,107
$0.00
1
$0
2020-11-05
2020-11-09
BALDASARE BRYAN
Exec VP & CFO
A - Grant
Stock Options (Right to Buy)
12,107
$0.00
1
$0
2020-06-30
2020-07-02
BALDASARE BRYAN
Exec VP & CFO
M - Exercise
Stock Options (Right to Buy)
-1,500
$0.00
1
$0
2020-02-21
2020-02-24
KENNY JOHN
Chief Executive Officer
P - Purchase
Common Stock
10,000
$8.00
80,000
1
$0